Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8441848 | European Journal of Cancer | 2015 | 8 Pages |
Abstract
Young patients present with more advanced disease and have more unfavourable tumour characteristics compared with middle-aged patients. Despite these characteristics, survival rates are equal, and young age is a prognostic factor for better survival. Although the use of adjuvant chemotherapy is controversial, a positive correlation with survival was found in this study.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Ricardo G. Orsini, Rob H.A. Verhoeven, Valery E.P.P. Lemmens, Liza N. van Steenbergen, Ignace H.J.T. de Hingh, Grard A.P. Nieuwenhuijzen, Harm J.T. Rutten,